You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic Pulmonary Fibrosis (IPF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial (Axatilimab, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Nov 9, 2023

Idiopathic Pulmonary Fibrosis Trial in Beijing (SC1011, Placebo comparator)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 4, 2023

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
May 15, 2023

Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ifetroban Sodium
  • Placebo
  • (no location specified)
Jan 25, 2023

Idiopathic Pulmonary Fibrosis Trial (TDI01 suspension)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • TDI01 suspension
  • (no location specified)
Oct 30, 2023

Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • REGEND001
  • Placebo
  • Beijing, Beijing, China
  • +2 more
Oct 7, 2023

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Active, not recruiting
  • Pulmonary Fibrosis
    • Pittsburgh, Pennsylvania
      University of Pittsburgh
    Dec 13, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial in China, United States (INS018_055, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Los Angeles, California
    • +9 more
    Jul 6, 2023

    Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • nalbuphine ER
    • Placebo
    • (no location specified)
    Jul 19, 2023

    Idiopathic Pulmonary Fibrosis (IPF)

    Active, not recruiting
    • Pulmonary Fibrosis
      • Pittsburgh, Pennsylvania
        University of Pittsburgh
      Dec 13, 2022

      Idiopathic Pulmonary Fibrosis Trial in London (LTI-03, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • London, United Kingdom
        Study Site
      Jul 18, 2023

      Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (INS018_055, Placebo)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Los Angeles, California
      • +8 more
      Jul 27, 2023

      Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • REGEND001 Autologous Therapy Product
      • Beijing, Beijing, China
      • +2 more
      Dec 19, 2022

      All-Case Surveillance of Ofev in Patients With IPF in Japan

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Multiple Locations, Japan
        (unnamed)
      Jan 23, 2023

      Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Human umbilical cord mesenchymal stem cell injection
      • Shanghai, Shanghai, China
        Shanghai Sixth People's Hospital
      Jul 29, 2022

      IPF Trial in China (PMG1015, PMG1015 )

      Recruiting
      • IPF
      • Beijing, Beijing, China
      • +5 more
      May 31, 2023

      Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux Trial in Tucson (Positive Airway Pressure)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • +2 more
      • Positive Airway Pressure
      • Tucson, Arizona
        University of Arizona
      Sep 15, 2022

      Idiopathic Pulmonary Fibrosis Trial (Cudetaxestat (BLD-0409), Control: Matching Placebo)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • Cudetaxestat (BLD-0409)
      • Control: Matching Placebo
      • (no location specified)
      May 12, 2022

      Idiopathic Pulmonary Fibrosis (IPF) Trial in United States (Saracatinab, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis (IPF)
      • Denver, Colorado
      • +3 more
      Jan 27, 2023

      Idiopathic Pulmonary Fibrosis, IPF Trial in Hershey (tipelukast, Placebo)

      Completed
      • Idiopathic Pulmonary Fibrosis
      • IPF
      • Hershey, Pennsylvania
        Penn State University College of Medicine, Milton S. Hershey Med
      Apr 25, 2022

      Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Boston, Massachusetts
        Massachusetts General Hospital
      Nov 14, 2022

      Pulmonary Fibrosis Trial (A wearable cough monitoring device, the Strados Labs RESP?? sensor, with an accompanying mobile

      Not yet recruiting
      • Pulmonary Fibrosis
      • A wearable cough monitoring device, the Strados Labs RESPᵀᴹ sensor, with an accompanying mobile application (App) for data collection
      • (no location specified)
      Jan 9, 2023

      Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under

      Active, not recruiting
      • Idiopathic Pulmonary Fibrosis
      • Alexandroupoli, Greece
      • +9 more
      Aug 22, 2022

      Dyspnea and Idiopathic Pulmonary Fibrosis

      Recruiting
      • Pulmonary Fibrosis
        • Lille, France
          Hop Calmette Chu Lille
        Mar 28, 2022

        Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)

        Recruiting
        • Interstitial Lung Diseases
        • Wenzhou, Zhejiang, China
          The First Affiliated Hospital of Wenzhou Medical University
        Apr 13, 2023